TI
IMGN

Trexquant Investment’s Immunogen Inc IMGN Stock Holding History

Trexquant Investment’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-200,746
Closed -$3.19M – 1888
2023
Q3 		$3.19M Buy
200,746
+123,379
+159% +$2.05M 0.08% 345
2023
Q2 		$1.46M Buy
+77,367
New +$913K 0.04% 611
2022
Q2 		– Sell
-107,126
Closed -$510K – 1961
2022
Q1 		$510K Sell
107,126
-1,853
-2% -$10.3K 0.02% 766
2021
Q4 		$809K Buy
108,979
+85,947
+373% +$534K 0.05% 460
2021
Q3 		$131K Sell
23,032
-8,671
-27% -$50.1K 0.01% 1025
2021
Q2 		$209K Sell
31,703
-7,924
-20% -$55.3K 0.02% 891
2021
Q1 		$321K Sell
39,627
-44,090
-53% -$360K 0.03% 714
2020
Q4 		$540K Buy
+83,717
New +$488K 0.06% 419
2018
Q2 		– Sell
-331,215
Closed -$3.48M – 1307
2018
Q1 		$3.48M Buy
331,215
+217,244
+191% +$2.15M 0.24% 108
2017
Q4 		$731K Buy
113,971
+9,338
+9% +$57.6K 0.08% 380
2017
Q3 		$800K Buy
104,633
+71,936
+220% +$478K 0.2% 130
2017
Q2 		$232K Buy
+32,697
New +$150K 0.06% 598
2016
Q3 		– Sell
-57,444
Closed -$177K – 1063
2016
Q2 		$177K Buy
+57,444
New +$360K 0.02% 787
2015
Q4 		– Sell
-74,300
Closed -$713K – 1326
2015
Q3 		$713K Sell
74,300
-57,800
-44% -$845K 0.06% 572
2015
Q2 		$1.9M Buy
+132,100
New +$1.45M 0.21% 100

Other funds holding IMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Trexquant Investment's IMGN Position: Q4 2023 in Review

Trexquant Investment sold out of Immunogen Inc (IMGN) in Q4 2023, closing a stake of 200,746 shares — an estimated $3.19M sold.

Trexquant Investment first reported a position in IMGN in Q2 2015 and held it in 15 quarters. The position peaked at $3.48M in Q1 2018. 327 funds tracked by Wall St. Rank hold IMGN as of Q4 2023.

  • Trexquant Investment reported no remaining Immunogen Inc position as of Q4 2023 after selling out during the quarter.
  • Trexquant Investment sold 200,746 Immunogen Inc shares in Q4 2023, an estimated $3.19M.
  • Trexquant Investment first reported a position in Immunogen Inc in Q2 2015 and held it in 15 quarters.
  • Trexquant Investment's Immunogen Inc position peaked at $3.48M in Q1 2018.
  • 327 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2023.

Based on Trexquant Investment's 13F filing for Q4 2023, filed 9 Feb 2024.